Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $36.73M.
ENTERPRISE VALUE (EV)
$36.73M
Biomea Fusion, Inc.
Market Cap
$92.54M
Enterprise Value (EV)
$36.73M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Biomea Fusion, Inc. (BMEA) | $92.54M | $36.73M |
| electroCore, Inc. (ECOR)vs › | $92.41M | $93.47M |
| Conexeu Sciences Inc. (CNXU)vs › | $88.97M | N/A |
| Cardiff Oncology, Inc. (CRDF)vs › | $88.63M | $79.89M |
| ImmuCell Corporation (ICCC)vs › | $88.21M | $91.79M |
| CareCloud, Inc. (CCLD)vs › | $87.96M | $128.58M |
| Equillium, Inc. (EQ)vs › | $87.88M | $31.30M |
| Anixa Biosciences, Inc. (ANIX)vs › | $99.01M | $97.78M |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $85.60M | $46.30M |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $84.79M | $91.44M |
Market Cap
$92.54M
Total Debt
$0.00
Cash
$55.81M
Enterprise Value
$36.73M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
